Glaxo Sells Rights to Auto-Immune Drug to Novartis
Permalink

Glaxo Sells Rights to Auto-Immune Drug to Novartis

LONDON (MarketWatch) – GlaxoSmithKline PLC is selling its remaining rights to a drug for use…

Continue Reading →

Drugmakers May Need Indemnity for Fast-Tracked Ebola Vaccines
Permalink

Drugmakers May Need Indemnity for Fast-Tracked Ebola Vaccines

  (Reuters) – Drugmakers are looking for some kind of indemnity from governments or multilateral…

Continue Reading →

China Fines GlaxoSmithKline $492M for Bribery
Permalink

China Fines GlaxoSmithKline $492M for Bribery

JOE McDONALD, AP Business Writer BEIJING (AP) — Drug maker GlaxoSmithKline was fined $492 million…

Continue Reading →

Studies Show Big Promise for HIV Prevention Drug
Permalink

Studies Show Big Promise for HIV Prevention Drug

MARILYNN MARCHIONE, AP Chief Medical Writer Exciting research suggests that a shot every one to…

Continue Reading →

GlaxoSmithKline Drug Fails in Late-Stage Study
Permalink

GlaxoSmithKline Drug Fails in Late-Stage Study

TOM MURPHY, AP Business Writer A potential GlaxoSmithKline heart disease treatment acquired in a key…

Continue Reading →